Dolutegravir/Lamivudine Efficacy and Safety Outcomes in People With HIV-1 With or Without Historical Resistance Results at Screening: 48-Week Pooled Analysis.
Open Forum Infect Dis
; 11(7): ofae365, 2024 Jul.
Article
in En
| MEDLINE
| ID: mdl-39015350
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Open Forum Infect Dis
Year:
2024
Document type:
Article
Affiliation country:
Alemania
Country of publication:
Estados Unidos